Free Trial

bioMérieux (OTCMKTS:BMXMF) Stock Price Crosses Below 50-Day Moving Average - Should You Sell?

bioMérieux logo with Medical background

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $113.87 and traded as low as $112.89. bioMérieux shares last traded at $112.89, with a volume of 9,557 shares changing hands.

Wall Street Analyst Weigh In

Separately, UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research report on Thursday, August 22nd.

Read Our Latest Analysis on bioMérieux

bioMérieux Price Performance

The firm's 50-day moving average is $113.95 and its 200-day moving average is $106.90. The company has a current ratio of 2.03, a quick ratio of 1.19 and a debt-to-equity ratio of 0.09.

bioMérieux Company Profile

(Get Free Report)

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.

See Also

Should you invest $1,000 in bioMérieux right now?

Before you consider bioMérieux, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and bioMérieux wasn't on the list.

While bioMérieux currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?
Post-Election Chaos or Opportunity? Prepare Your Investments

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines